Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Recruiting2

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT07086768Phase 1Recruiting
Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors
Advanced Solid TumorMetastatic Solid TumorSolid Tumor
StudydirectorStart date: 2026-01-26
NCT05604560Phase 2Recruiting
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer
Pancreatic Cancer
PrincipalinvestigatorStart date: 2023-11-08

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

The University of Texas Health Science Center at San Antonio

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

John Sarantopoulos, MD

The University of Texas Health Science Center at San Antonio

Moderately Similar
3 trials

Shared therapeutic areas:

Advanced Solid TumorMetastatic Solid TumorSolid Tumor

Worked with same sponsors:

Biosion, Inc.Lei Zheng
Collaborated on 1 trial
Similarity Score34%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Cancer of PancreasSolid TumorAdvanced Solid Tumor
Similarity Score23%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Solid TumorAdvanced Solid Tumor
Similarity Score15%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

Advanced Solid TumorSolid Tumor
Similarity Score15%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Cancer of PancreasSolid Tumor
Similarity Score15%

Jason Wu

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Related
31 trials

Shared therapeutic areas:

Advanced Solid TumorSolid Tumor
Similarity Score15%

Mike Royal, MD

Sorrento Therapeutics, Inc.

Related
19 trials

Shared therapeutic areas:

Solid TumorCancer of Pancreas
Similarity Score15%

lin shen

Peking University Cancer Hospital & Institute

Related
31 trials

Shared therapeutic areas:

Advanced Solid TumorSolid Tumor
Similarity Score15%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Cancer of Pancreas
Similarity Score8%

Zhaoping Li, MD, PhD

University of California, Los Angeles

Related
17 trials

Shared therapeutic areas:

Cancer of Pancreas
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT07086768Phase 1StudyDirector

Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors

Advanced Solid TumorMetastatic Solid TumorSolid Tumor
Recruiting
NCT05604560Phase 2PrincipalInvestigator

A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer

Pancreatic Cancer
Recruiting

All 2 trials loaded